(44.200.122.214)
[ij] [ij] [ij] 
Email id
 

Current Trends in Biotechnology and Pharmacy
Year : 2019, Volume : 13, Issue : 2
First page : ( 124) Last page : ( 145)
Print ISSN : 0973-8916. Online ISSN : 2230-7303.

Quantitative Structure-activity Relationship based Design, Synthesis, and Evaluation of Novel Diarylether Derivatives as a potent Acetylcholinesterase inhibitor and Antioxidant to treat Cognitive dysfunctions

Srivastava Pavan1, Tripathi Prabhash Nath1, Sharma Piyoosh1, Shrivastava Sushant K1,*

1Pharmaceutical Chemistry Research Laboratory Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, (Banaras Hindu University), Varanasi-221005, Uttar Pradesh, India

*For Correspondence - skshrivastava.phe@itbhu.ac.in

Online published on 30 December, 2019.

Abstract

Some promising acetylcholinesterase (AChE) inhibitors with an antioxidant potential were designed, synthesised, and evaluated for their role in treating cognitive dysfunctions. The in silico Gaussian-based quantitative structureactivity relationship (QSAR), virtual screening (VS), QikProp drug-likeliness prediction and docking pose filtration protocols were adapted to design and screen the novel series of diaryl ether derivatives. Further, the selected compounds were investigated for their molecular binding stability using molecular dynamics (MD) simulation analysis and molecular mechanics generalised born surface area (MM-GBSA). The identified hits were synthesised and evaluated for their in vitro AChE inhibition and antioxidant potential. Among all the synthesized compounds, the compound 39 was observed as potent AChE inhibitor (AChE IC50 = 1.30 ± 0.09 μm; Ki = 0.054 ± 0.009 μM), and also the antioxidant potential of compound 39 (52.9%) was observed significantly better than standard donepezil (<10%) and parallel to ascorbic acid (56.6%). Further, compound 39 ameliorated the scopolamine-induced cognitive impairment in the Y-maze and passive avoidance testsin mice models. Ex vivo and biochemical analysis established the brain AChE inhibitory potential and antioxidant properties of compound 39. The results signified compound 39 to be a promising lead for the treatment of cognitive dysfunctions.

Top

Keywords

QSAR, virtual screening, diaryl ether, acetylcholinesterase, antioxidant.

Top

 
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
815,240,853 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.